BioCentury | May 6, 2013
Company News

Lentigen, Nanolek LLC deal

...companies signed a memorandum of understanding to produce a virus-like particle (VLP)-based flu vaccine at Nanolek's...
...to be signed late this year, Lentigen will license vectors, cell lines and technology to Nanolek...
...trials are expected to be completed by late 2014, with clinical trials slated for 2015. Nanolek...
Items per page:
1 - 1 of 1
BioCentury | May 6, 2013
Company News

Lentigen, Nanolek LLC deal

...companies signed a memorandum of understanding to produce a virus-like particle (VLP)-based flu vaccine at Nanolek's...
...to be signed late this year, Lentigen will license vectors, cell lines and technology to Nanolek...
...trials are expected to be completed by late 2014, with clinical trials slated for 2015. Nanolek...
Items per page:
1 - 1 of 1